137 related articles for article (PubMed ID: 9185712)
1. Loss of expression of receptor tyrosine kinase family genes PTK7 and SEK in metastatic melanoma.
Easty DJ; Mitchell PJ; Patel K; Flørenes VA; Spritz RA; Bennett DC
Int J Cancer; 1997 Jun; 71(6):1061-5. PubMed ID: 9185712
[TBL] [Abstract][Full Text] [Related]
2. Abnormal protein tyrosine kinase gene expression during melanoma progression and metastasis.
Easty DJ; Herlyn M; Bennett DC
Int J Cancer; 1995 Jan; 60(1):129-36. PubMed ID: 7814145
[TBL] [Abstract][Full Text] [Related]
3. Intertumoral heterogeneity of receptor-tyrosine kinases expression in human melanoma cell lines with different metastatic capabilities.
Gutman M; Singh RK; Radinsky R; Bar-Eli M
Anticancer Res; 1994; 14(5A):1759-65. PubMed ID: 7847808
[TBL] [Abstract][Full Text] [Related]
4. Novel and known protein tyrosine kinases and their abnormal expression in human melanoma.
Easty DJ; Ganz SE; Farr CJ; Lai C; Herlyn M; Bennett DC
J Invest Dermatol; 1993 Nov; 101(5):679-84. PubMed ID: 8228328
[TBL] [Abstract][Full Text] [Related]
5. Loss of expression of protein kinase C beta is a common phenomenon in human malignant melanoma: a result of transformation or differentiation?
Gilhooly EM; Morse-Gaudio M; Bianchi L; Reinhart L; Rose DP; Connolly JM; Reed JA; Albino AP
Melanoma Res; 2001 Aug; 11(4):355-69. PubMed ID: 11479424
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of the Promigratory and Prometastatic PTK7 Receptor Is Associated with an Adverse Clinical Outcome in Colorectal Cancer.
Lhoumeau AC; Martinez S; Boher JM; Monges G; Castellano R; Goubard A; Doremus M; Poizat F; Lelong B; de Chaisemartin C; Bardin F; Viens P; Raoul JL; Prebet T; Aurrand-Lions M; Borg JP; Gonçalves A
PLoS One; 2015; 10(5):e0123768. PubMed ID: 25962058
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of Lerk-5/Eplg5 messenger RNA: a novel marker for increased tumorigenicity and metastatic potential in human malignant melanomas.
Vogt T; Stolz W; Welsh J; Jung B; Kerbel RS; Kobayashi H; Landthaler M; McClelland M
Clin Cancer Res; 1998 Mar; 4(3):791-7. PubMed ID: 9533549
[TBL] [Abstract][Full Text] [Related]
8. Protein B61 as a new growth factor: expression of B61 and up-regulation of its receptor epithelial cell kinase during melanoma progression.
Easty DJ; Guthrie BA; Maung K; Farr CJ; Lindberg RA; Toso RJ; Herlyn M; Bennett DC
Cancer Res; 1995 Jun; 55(12):2528-32. PubMed ID: 7780963
[TBL] [Abstract][Full Text] [Related]
9. Gene expression analysis after receptor tyrosine kinase activation reveals new potential melanoma proteins.
Teutschbein J; Haydn JM; Samans B; Krause M; Eilers M; Schartl M; Meierjohann S
BMC Cancer; 2010 Jul; 10():386. PubMed ID: 20663135
[TBL] [Abstract][Full Text] [Related]
10. PTK 7 is a transforming gene and prognostic marker for breast cancer and nodal metastasis involvement.
Gärtner S; Gunesch A; Knyazeva T; Wolf P; Högel B; Eiermann W; Ullrich A; Knyazev P; Ataseven B
PLoS One; 2014; 9(1):e84472. PubMed ID: 24409301
[TBL] [Abstract][Full Text] [Related]
11. Receptor tyrosine kinases and their activation in melanoma.
Easty DJ; Gray SG; O'Byrne KJ; O'Donnell D; Bennett DC
Pigment Cell Melanoma Res; 2011 Jun; 24(3):446-61. PubMed ID: 21320293
[TBL] [Abstract][Full Text] [Related]
12. Several receptor tyrosine kinase genes of the Eph family are segmentally expressed in the developing hindbrain.
Becker N; Seitanidou T; Murphy P; Mattéi MG; Topilko P; Nieto MA; Wilkinson DG; Charnay P; Gilardi-Hebenstreit P
Mech Dev; 1994 Jul; 47(1):3-17. PubMed ID: 7947319
[TBL] [Abstract][Full Text] [Related]
13. A juxtamembrane autophosphorylation site in the Eph family receptor tyrosine kinase, Sek, mediates high affinity interaction with p59fyn.
Ellis C; Kasmi F; Ganju P; Walls E; Panayotou G; Reith AD
Oncogene; 1996 Apr; 12(8):1727-36. PubMed ID: 8622893
[TBL] [Abstract][Full Text] [Related]
14. Protein tyrosine phosphatase genes downregulated in melanoma.
McArdle L; Rafferty M; Maelandsmo GM; Bergin O; Farr CJ; Dervan PA; O'Loughlin S; Herlyn M; Easty DJ
J Invest Dermatol; 2001 Nov; 117(5):1255-60. PubMed ID: 11710941
[TBL] [Abstract][Full Text] [Related]
15. Catalytically defective receptor protein tyrosine kinase PTK7 enhances invasive phenotype by inducing MMP-9 through activation of AP-1 and NF-κB in esophageal squamous cell carcinoma cells.
Shin WS; Hong Y; Lee HW; Lee ST
Oncotarget; 2016 Nov; 7(45):73242-73256. PubMed ID: 27689325
[TBL] [Abstract][Full Text] [Related]
16. Characterisation of the Sek-1 receptor tyrosine kinase.
Becker N; Gilardi-Hebenstreit P; Seitanidou T; Wilkinson D; Charnay P
FEBS Lett; 1995 Jul; 368(2):353-7. PubMed ID: 7628636
[TBL] [Abstract][Full Text] [Related]
17. 18F-Labeled Single-Stranded DNA Aptamer for PET Imaging of Protein Tyrosine Kinase-7 Expression.
Jacobson O; Weiss ID; Wang L; Wang Z; Yang X; Dewhurst A; Ma Y; Zhu G; Niu G; Kiesewetter DO; Vasdev N; Liang SH; Chen X
J Nucl Med; 2015 Nov; 56(11):1780-1785. PubMed ID: 26315836
[TBL] [Abstract][Full Text] [Related]
18. RaLP, a new member of the Src homology and collagen family, regulates cell migration and tumor growth of metastatic melanomas.
Fagiani E; Giardina G; Luzi L; Cesaroni M; Quarto M; Capra M; Germano G; Bono M; Capillo M; Pelicci P; Lanfrancone L
Cancer Res; 2007 Apr; 67(7):3064-73. PubMed ID: 17409413
[TBL] [Abstract][Full Text] [Related]
19. Deletion in p16INK4a and loss of p16 expression in human skin primary and metastatic melanoma cells.
Zhang H; Rosdahl I
Int J Oncol; 2004 Feb; 24(2):331-5. PubMed ID: 14719109
[TBL] [Abstract][Full Text] [Related]
20. The differential expression of protein kinase C genes in normal human neonatal melanocytes and metastatic melanomas.
Yamanishi DT; Graham M; Buckmeier JA; Meyskens FL
Carcinogenesis; 1991 Jan; 12(1):105-9. PubMed ID: 1988168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
